American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic anterior optic neuropathy (NAION).

Polar Capital Global Healthcare, which is co-managed by James Douglas, currently trades at a 3pc discount to its assets.

Several local companies are developing technologies that they hope could replace a painful poke with something that feels more like having Velcro against your skin for a few minutes.

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

GLP-1 medications that have helped people lose weight may also help people drink less alcohol, according to new ...

Aja Beckett quit her job after her app for tracking weight-loss shots, Shotsy, took off on Reddit.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

On the one hand, we see the rise of weight-loss drugs like Ozempic, hailed as a revolutionary aid for those who can afford it. Conversely, the body positivity movement encourages self-acceptance ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite earlier hopes, a rigorous 96-week trial with 194 participants found no ...

By now, these are household names: Mounjaro. Wegovy. Zepbound… and yes, Ozempic. A Kaiser Family Foundation poll found that one in 8 American adults reported trying a GLP-1 medication.

Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds By India Edwards HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could ...